Call to all those doing #BPH surgery and looking at impact on ejaculation. We NEED to go beyond the simplistic MSHQ-EJD (3 questions)) to a sperm analysis and post orgasm urine analysis ==> 1) quantify ejaculate volume with comparison to baseline. Report anejac and retro! #EAU19
And another one by @Paolo_Capog #erectiledysfunction #MensHealth with @drserefoglu @MikkelFode #EAU19 https://t.co/kDluprPgZh
Thanks @Dr_KevinZorn for presenting our collaboration. Two great technologies #rezum #urolift giving men options. Each one has advantages. Great time for #BPH #MIST #EAU19 https://t.co/lsdexaqZ7c
Antioxidants appear to have not only beneficial effects, but also significant detrimental effects on sperm functions in the treatment of infertile men! #EAU19 #ESAU @MikkelFode @JSnksen @PaoloVerze @Paolo_Capog @TheTurekClinic @PNSchlegel @DlambJ https://t.co/WvVq68HTu3
What’s new in prostate cancer screening in 2019? Exciting poster session starting now at 15:45 in Green area Room 1 #EAU19 @Uroweb @DrFAbdollah https://t.co/4M6xEetFxi
#EAU19 @pravi5ha presents 5-year subjective outcome data on female #SUI surgery #incontinence https://t.co/AXsaIg5qjf
A book-lover and an EAU member? Avail yourself of big discounts at the EAU booth (G60) and increase your book collection.
#EAU19 https://t.co/H2SITaY3dL
Impressive multi-level genomics of UTUC by Y. Fujii. #EAU19 Intersting differences and similarites compared to #bladdercancer
More RAS mutations and stronger link between FGFR3 mutation and RNA-cluster in UTUC.
Which effects are due to different T-stage distributions? https://t.co/GoOdH0bYkQ
Charing #andrology session w professor @drserefoglu at #EAU19. Excellent discussion and new knowledge! https://t.co/Od2gckeKgB
Masterful presentation of the 4yr Rezum data from the pivotal study – low rates of retreatment extending to 4 years now. #EAU19 #TreatBPH https://t.co/ce2iCzBg1H
Great presentation by @FraClaps at European Congress on predictive value of inflammation and immuno-nutritional markers on perioperative and postoperative morbidity and mortality after radical cystectomy! #EAU19 https://t.co/k9BZ0hUIVS
Do we really need to maintain LHRH therapy when prescribing androgen receptor axis targeted drugs? Initial results from the SPARE trial #Eau19 @ch_ohlmann @Uroweb https://t.co/EbRSwZNNt5
Four-year data on Rezum presented by @clausroehrborn, includes IPSS, Qmax, QOL, and retreatment rates. #EAU19 https://t.co/z1g1LBRpV9
EAU membership exclusive: early access to book hotels in London!